Atlas Trials

A Pharmacokinetic Study of YM178 in Normal Subjects and Those With Mild, Moderate, and Severe Renal Impairment

Clinical trial NCT00750620 · COMPLETED

Trial details

NCT number
NCT00750620
Sponsor
Astellas Pharma Inc
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Renal Impairment
Start date
2008-09-01
Primary completion
2009-09-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.